Prospect Capital PSEC stock analysis – Is PSEC stock a good investment?

EMA accepts Deciphera’s MAA for cell tumour treatment for review

Vimseltinib is intended to treat tenosynovial giant cell tumour. Credit: crystal light / Shutterstock. The European Medicines Agency (EMA) has accepted for review the marketing

July 19, 2024

GSK to pay $2.2 billion to settle most Zantac lawsuits over claims the heartburn pill causes cancer

After protracted legal battling, GSK has agreed to pay $2.2 billion to settle most of the pending lawsuits that claimed a discontinued version of the

October 9, 2024

FDA Approves First Emergency Allergy Nasal Spray

The first non-injectable emergency treatment for allergies is anticipated to hit shelves following FDA approval of the neffy epinephrine nasal spray. The product from ARS

August 10, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.